首页> 外文期刊>JAMA: the Journal of the American Medical Association >Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.
【24h】

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

机译:辅助化疗开始时间与大肠癌生存率之间的关联:系统评价和荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Adjuvant chemotherapy (AC) improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. OBJECTIVE: To determine the relationship between time to AC and survival outcomes via a systematic review and meta-analysis. data sources: MEDLINE (1975 through January 2011), EMBASE, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched to identify studies that described the relationship between time to AC and survival. STUDY SELECTION: Studies were only included if the relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. DATA EXTRACTION: Hazard ratios (HRs) for overall survival and disease-free survival from each study were converted to a regression coefficient (beta) and standard error corresponding to a continuous representation per 4 weeks of time to AC. The adjusted beta from individual studies were combined using a fixed-effects model. Inverse variance (1/SE(2)) was used to weight individual studies. Publication bias was investigated using the trim and fill approach. RESULTS: We identified 10 eligible studies involving 15,410 patients (7 published articles, 3 abstracts). Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy. Six studies reported time to AC as a binary variable and 4 as 3 or more categories. Meta-analysis demonstrated that a 4-week increase in time to AC was associated with a significant decrease in both overall survival (HR, 1.14; 95% confidence interval [CI], 1.10-1.17) and disease-free survival (HR, 1.14; 95% CI, 1.10-1.18). There was no significant heterogeneity among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight. CONCLUSION: In a meta-analysis of the available literature on time to AC, longer time to AC was associated with worse survival among patients with resected colorectal cancer.
机译:背景:辅助化疗(AC)可改善结直肠癌切除患者的生存率。但是,从手术到开始AC的最佳时机尚不清楚。目的:通过系统的回顾和荟萃分析来确定AC的时间与生存结果之间的关系。数据来源:检索MEDLINE(1975年至2011年1月),EMBASE,系统评价的Cochrane数据库和对照试验的Cochrane中央登记册,以鉴定描述AC时间与生存时间之间关系的研究。研究选择:仅在充分描述了相关预后因素并且比较组达到平衡或针对这些预后因素调整了结果后,才纳入研究。数据提取:将每项研究的总生存期和无病生存期的危险比(HRs)转换为回归系数(beta)和标准误,对应于每4周持续暴露于AC的情况。使用固定效应模型合并了来自各个研究的调整后的beta。逆方差(1 / SE(2))用于加权单个研究。使用修整和填充方法研究出版偏差。结果:我们确定了10项合格研究,涉及15,410例患者(7篇发表文章,3篇摘要)。其中有9项研究是基于队列研究或基于人群的研究,而1项研究是来自化学疗法随机试验的次要分析。六项研究将交流时间报告为二进制变量,将四项报告为3个或更多类别。荟萃分析显示,到AC时间延长4周与总体生存率(HR,1.14; 95%置信区间[CI],1.10-1.17)和无病生存期(HR,1.14)显着降低有关。 ; 95%CI,1.10-1.18)。纳入研究之间没有显着的异质性。在对潜在的出版偏倚进行调整后以及在重复分析以排除最大权重的研究后,结果仍然很显着。结论:在对AC可用时间的现有文献的荟萃分析中,较长的AC时间与切除大肠癌患者的生存期较差有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号